Compare ARMP & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARMP | LARK |
|---|---|---|
| Founded | N/A | 1885 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.7M | 190.1M |
| IPO Year | 1996 | 2001 |
| Metric | ARMP | LARK |
|---|---|---|
| Price | $3.02 | $32.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.50 | N/A |
| AVG Volume (30 Days) | ★ 75.7K | 4.4K |
| Earning Date | 11-12-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | N/A | ★ 35.84 |
| EPS | N/A | ★ 2.59 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.40 | $23.57 |
| 52 Week High | $14.98 | $34.60 |
| Indicator | ARMP | LARK |
|---|---|---|
| Relative Strength Index (RSI) | 46.59 | 54.16 |
| Support Level | $2.77 | $30.92 |
| Resistance Level | $3.96 | $33.13 |
| Average True Range (ATR) | 0.44 | 0.32 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 43.35 | 85.42 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and Southwest Kansas.